Collegium Pharmaceutical Inc (COLL) — Cash Flow Quality Index
Collegium Pharmaceutical Inc (COLL) has a Cash Flow Quality Index of 2.49x as of September 2025. Operating cash flow of $78.44 Million exceeds net income of $31.51 Million, indicating high earnings quality where cash backs reported profits. Explore COLL cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Collegium Pharmaceutical Inc Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Collegium Pharmaceutical Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Collegium Pharmaceutical Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Collegium Pharmaceutical Inc (2020–2024)
Year-by-year earnings quality comparison for Collegium Pharmaceutical Inc. For live market cap and the full company financial profile, see COLL stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.96x | $204.98 Million | $69.19 Million | ▼ -48.1% |
| 2023 | 5.71x | $274.75 Million | $48.16 Million | ▲ +294.0% |
| 2021 | 1.45x | $103.56 Million | $71.52 Million | ▼ -58.8% |
| 2020 | 3.51x | $93.94 Million | $26.75 Million | — |